Skip to content

ACCUSTEM SCIENCES, INC.

ACUT

CIK 0001850767

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$1.73M
−16.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.10
+7.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$1.36M
Q1 May 2026
Cash
—
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
16.07M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Recent filings